RVL Pharmaceuticals (FRA:O1P) Short-Term Debt : €53.30 Mil (As of Jun. 2023)

View and export this data going back to 2018. Start your Free Trial

What is RVL Pharmaceuticals Short-Term Debt?

RVL Pharmaceuticals's Short-Term Debt for the quarter that ended in Jun. 2023 was €53.30 Mil.

RVL Pharmaceuticals's quarterly Short-Term Debt increased from Dec. 2022 (€1.35 Mil) to Mar. 2023 (€3.88 Mil) and increased from Mar. 2023 (€3.88 Mil) to Jun. 2023 (€53.30 Mil).

RVL Pharmaceuticals's annual Short-Term Debt increased from Dec. 2020 (€0.00 Mil) to Dec. 2021 (€2.13 Mil) but then declined from Dec. 2021 (€2.13 Mil) to Dec. 2022 (€1.35 Mil).

RVL Pharmaceuticals Short-Term Debt Historical Data

The historical data trend for RVL Pharmaceuticals's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

RVL Pharmaceuticals Short-Term Debt Chart

RVL Pharmaceuticals Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Short-Term Debt

Get a 7-Day Free Trial

1.56

2.13

1.35

RVL Pharmaceuticals Quarterly Data
	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23
Short-Term Debt	Get a 7-Day Free Trial															0.57	-	1.35	3.88	53.30

RVL Pharmaceuticals Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

RVL Pharmaceuticals Short-Term Debt Related Terms

Thank you for viewing the detailed overview of RVL Pharmaceuticals's Short-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

RVL Pharmaceuticals (FRA:O1P) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » RVL Pharmaceuticals PLC (FRA:O1P) » Definitions » Short-Term Debt

Comparable Companies

Traded in Other Exchanges

RVLPQ:USA

Address

400 Crossing Boulevard, Bridgewater, NJ, USA, 08807

Website

https://www.rvlpharma.com

RVL Pharmaceuticals PLC is a pharmaceutical company focused on the commercialization and development of products that target markets with underserved patient populations in the ocular medicine and medical aesthetics therapeutic areas. Its revenues consist of product sales, royalty revenues and licensing revenue.

RVL Pharmaceuticals (FRA:O1P) Headlines

No Headlines